10 November 2020

SCI-RSC Challenges in Catalysis VII

Organised by:

SCI's Fine Chemicals group and RSC’s Applied Catalysis Group

London, UK

Register your interest

Registration Closed

This event is no longer available for registration.


The SCI’s Fine Chemicals Group and the RSC’s Applied Catalysis Group are pleased to announce this one-day biennial symposium - Challenges in Catalysis for Pharmaceuticals and Fine chemicals VII. The aim of this meeting, well-supported both by industry and academia is to debate the current developments in catalysis, where they are going and what industry needs.  An exciting line up of leading academic and industrial scientists will present a series of lectures covering areas such as C-H activation, olefin metathesis, biochemistry and new catalytic methods.


This meeting is suitable for all organic/medicinal chemists (early and mid-career) working in academia and industry and chemical engineers in process development.


The programme will be announced in due course.

Confirmed speakers
  • Prof Dr Christophe Copéret, ETH Zurich, Switzerland
  • Dr Martin Eastgate, Bristol-Myers Squibb, USA
  • Prof Corinna Schindler, University of Michigan, USA
  • Dr Samantha Staniland, Johnson Matthey, UK
  • Prof Nick Turner, University of Manchester, UK
Exhibition and Sponsorship

An exhibition will take place alongside the conference during refreshment breaks for companies and related organisations who may wish to exhibit. For further information and prices, please email conferences@soci.org. Spaces are limited and will be allocated on a first come, first served basis.

Venue and Contact


Burlington House

Conference Team

Tel: +44 (0)20 7598 1561

Email: conferences@soci.org

Booking Process/Deadlines

Booking terms and conditions

CPD Info

SCI Members attending this meeting are able to claim CPD points.

Accredited cpd Centre - The CPD Standards Office - CPD Provider 41057 - www.cpdstandards.com


Organising Committee
  • Emmanuel Callens, SCI/ Selcia
  • Amanda Jarvis, University of Edinburgh
  • Maria Luisa Palacios-Alcolado, SCI/ Johnson Mathey
  • Paul Murray, Catalysis Consulting
  • Katherine Wheelhouse, GlaxoSmithKline